Laws and sections by number or title, due dates, pages, and updates.
Kotak Special Situations Fund proposes to purchase certain equity shares in Biocon Biologics Limited. The acquirer invests in companies for capital appreciation. The target manufactures pharmaceutical formulations and biosimilars. The parties notify the combination through the green channel route because their activities do not exhibit horizontal, vertical, or complementary overlaps in any plausible relevant market in India.
What you must do
Who is affected
Ask about this competition order
SUMMARY OF THE PROPOSED COMBINATION
[UNDER REGULATION 13(1A) OF THE COMPETITION COMMISSION OF INDIA (PROCEDURE IN REGARD TO THE TRANSACTION OF BUSINESS RELATING TO COMBINATIONS) REGULATIONS, 2011 (AS AMENDED)]
(a) Name of the parties to the combination
(i) Kotak Special Situations Fund (“Acquirer”); and
(ii) Biocon Biologics Limited (“Target”).
(b) The nature and purpose of the combination
(c) The products, services, and business(es) of the parties to the combination
Acquirer
Target
(d) The respective markets in which the parties to the combination operate
The Parties’ activities do not exhibit any horizontal, vertical, or complementary overlaps in any of the plausible relevant markets in India.
Therefore, the Proposed Combination is being notified under the green channel route in terms of Regulation 5A and Schedule III of the Competition Commission of India (Procedure in regard to the transaction of business relating to combinations) Regulations, 2011 (as amended).